Authors
Loading...
Analysis reveals a rise in cosmetic iatrogenic botulism from counterfeit botulinum toxin, highlighting regulatory gaps.
Oliveira et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: